Arsen Osipov, MD, FACP

It’s infamous as a “silent disease,” with symptoms that rarely make themselves known until too late. But one Conquer Cancer-funded researcher may have found a way to improve the odds, even for patients with advanced-stage pancreatic cancer.

Ann Partridge, MD, MPH, FASCO

Patient participation in clinical trials is vital to advancing cancer research. Too often, however, a communication breakdown occurs between the physician and the patient. The result? Too many patients may never fully understand the research they took part in or the outcomes it yielded.

Pedro Isaacsson Velho, MD

Prostate cancer is the second leading cause of cancer-related death among men in the U.S.* and the fourth most diagnosed cancer worldwide.* While the standard treatment — androgen deprivation therapy (ADT) — targets prostate cancer even in its advanced stages, most patients rapidly develop resist

Sarah Nyagabona, MD, MMed

In Tanzania, HIV infection and breast cancer are major concerns. It’s becoming critical to research the overlap between these two diseases.